Ampio Pharmaceuticals Issues Letter to Stockholders
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and...
Source: prnewswire.com
Ampio Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ampio Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ampio Board Today - Breaking & Trending Today
Ampio Pharmaceuticals Issues Letter to Stockholders
ENGLEWOOD, Colo., Aug. 3, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockhold...
Source: businessinsider.com
Ampio Independent Committee to Conduct Investigation
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio" or the "Company") today announced that an independent special committee of the Ampio...
Source: prnewswire.com
Ampio Independent Committee to Conduct Investigation
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) ("Ampio" or the "Company") today announced that an independent special committee of the Ampio...
Source: prnewswire.com
Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
ENGLEWOOD, CO, November 22, 2021 – Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediat
Source: pressreleasepoint.com